Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_53_библиотеки_им_акад_М_И_Перельмана
.pdf
Coin F, Bergmann E, Tremeau-Bravard A, Egly JM (1999) Mutationsin XPB and XPD helicases
found in xeroderma pigmentosumpatients impair the transcription function of TFIIH. EMBO J
18:1357–1366
Conlin A, Smith G, Carey FA, Wolf CR, Steele RJ (2005) The prognostic significance of K-ras,
p53, and APC mutations in colorectal carcinoma. Gut 54(9):1283–1286. https://doi.org/10.
1136/gut.2005.066514
Coppedè F, Stoccoro A, Tannorella P, Gallo R, Nicolì V, Migliore L (2019) Association of
polymorphisms in genes involved in one-carbon metabolism with MTHFR methylation levels.
Int J Mol Sci 20(15):3754. https://doi.org/10.3390/ijms20153754
Daniel C, Howe JR (2008) Hamartomatous polyposis syndromes. Surg Clin North Am 88
(4):779–817. https://doi.org/10.1016/j.suc.2008.05.002
de la Chapelle A, Hampel H (2010) Clinical relevance of microsatellite instability in colorectal
cancer. J Clin Oncol 28(20):3380–3387. https://doi.org/10.1200/jco.2009.27.0652
De Rosa M, Pace U, Rega D et al (2015) Genetics, diagnosis and management of colorectal cancer
(review). Oncol Rep 34:1087–1096
Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25
(10):1010–1022. https://doi.org/10.1101/gad.2037511
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal cancer. Lancet 394
(10207):1467–1480. https://doi.org/10.1016/S0140-6736(19)32319-0
Desautels D, Czaykowski P, Nugent Z et al (2016) Risk of colorectal cancer after the diagnosis of
prostate cancer: a population-based study. Cancer 122:1254–1260
Ding W, Zhou DL, Jiang X, Lu LS (2013) Methionine synthase A2756G polymorphism and risk of
colorectal adenoma and cancer: evidence based on 27 studies. PLoS One 8(4):e60508. https://
doi.org/10.1371/journal.pone.0060508
Dotan E, Meropol NJ, Zhu F, Zambito F, Bove B, Cai KQ et al (2012) Relationship of increased
aurora kinase a gene copy number, prognosis and response to chemotherapy in patients with
metastatic colorectal cancer. Br J Cancer 106(4):748–755. https://doi.org/10.1038/bjc.2011.587
Doubeni CA et al (2012) Contribution of behavioral risk factors and obesity to socioeconomic
differences in colorectal cancer incidence. J Natl Cancer Inst 104:1353–1362
Du H, Guo N, Shi B, Zhang Q, Chen Z, Lu K, Shu Y, Chen T, Zhu L (2014) The effect of XPD
polymorphisms on digestive tract cancers risk: a meta-analysis. PLoS One 9(5):e96301. https://
doi.org/10.1371/journal.pone.0096301
Dumont P, Leu JI, Della Pietra AC, George DL, Murphy M (2003) The codon 72 polymorphic
variants of p53 have markedly different apoptotic potential. Nat Genet 33:357–365
Eder IE, Culig Z, Putz T, Nessler-Menardi C, Bartsch G, Klocker H (2001) Molecular biology of the
androgen receptor: from molecular understanding to the clinic. Eur Urol 40(3):241–251. https://
doi.org/10.1159/000049782
Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN et al (2010) Annual report
to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of
interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116
(3):544–573. https://doi.org/10.1002/cncr.24760
Eskandari E, Rezaifar A, Hashemi M (2017) XPG Asp1104His, XRCC2 Rs3218536 A/G and
RAD51 135G/C gene polymorphisms and colorectal cancer risk: a meta-analysis. Asian Pac J
Cancer Prev 18(7):1805–1813. https://doi.org/10.22034/APJCP.2017.18.7.1805
Essers J, Houtsmuller AB, van Veelen L, Paulusma C, Nigg AL, Pastink A et al (2002) Nuclear
dynamics of RAD52 group homologous recombination proteins in response to DNA damage.
EMBO J 21:2030–2037
Fearon ER (2011) Molecular genetics of colorectal cancer. Annu Rev Pathol 6:479–507
Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5):759–767
Fedirko V et al (2011) Alcohol drinking and colorectal cancer risk: an overall and dose-response
meta-analysis of published studies. Ann Oncol 22:1958–1972
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. (2018a) IARC cancer today
(powered by GLOBOCAN 2018). IARC Cancer Base number 15. https://publications.iarc.fr/
5 Colorectal Cancer and Genetic Polymorphism in Key Regulatory Low... 155
https://t.me/medicina_free
Databases/Iarc-Cancerbases/Cancer-Today-Powered-By-GLOBOCAN-2018. Accessed July
02 2020
Ferlay J, Ervik M, Lam F, et al. (2018b) Global cancer observatory: cancer today. Lyon, France:
International Agency for Research on Cancer. http://gco.iarc.fr/today/data/factsheets/cancers/
10_8_9-Colorectum-fact-sheet.pdf. Accessed 02 Nov 2018
Ferrer-Mayorga G, Larriba MJ, Crespo P, Muñoz A (2019) Mechanisms of action of vitamin D in
colon cancer. J Steroid Biochem Mol Biol 185:1–6. https://doi.org/10.1016/j.jsbmb.2018.07.
002
Figueiredo JC, Levine AJ, Crott JW, Baurley J, Haile RW (2013) Folate-genetics and colorectal
neoplasia: what we know and need to know next. Mol Nutr Food Res 57(4):607–627. https://
doi.org/10.1002/mnfr.201200278
Fleming M, Ravula S, Tatishchev SF, Wang HL (2012) Colorectal carcinoma: pathologic aspects. J
Gastrointest Oncol 3(3):153–173. https://doi.org/10.3978/j.issn.2078-6891.2012.030
Fodde R, Smits R, Clevers H (2001) APC, signal transduction and genetic instability in colorectal
cancer. Nat Rev Cancer 1(1):55–67. https://doi.org/10.1038/35094067
Forat-Yazdi M, Gholi-Nataj M, Neamatzadeh H, Nourbakhsh P, Shaker-Ardakani H (2015)
Association of XRCC1 Arg399Gln polymorphism with colorectal Cancer risk: a HuGEMeta
analysis of 35 studies. Asian Pac J Cancer Prev 16(8):3285–3291. https://doi.org/10.7314/apjcp.
2015.16.8.3285
Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mendel M,
Kidron M, Bar-On H (1999) A common mutation A1298C in human methylenetetrahydrofolate
reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr
129(9):1656–1661. https://doi.org/10.1093/jn/129.9.1656
Friso S, Choi SW (2005) Gene-nutrient interactions in one-carbon metabolism. Curr Drug Metab 6
(1):37–46
Fu Q, Zhang G, Chen H, Zheng Y, Cheng J (2013) Current evidence on the relationship between
SNP309 polymorphism in the MDM2 gene and colorectal cancer risk. Tumour Biol 34
(6):3721–3729. https://doi.org/10.1007/s13277-013-0956-z
Ganem NJ, Godinho SA, Pellman D (2009) A mechanism linking extra centrosomes to chromo-
somal instability. Nature 460(7252):278–282. https://doi.org/10.1038/nature08136
Gillessen S, Templeton A, Marra G et al (2010) Risk of colorectal cancer in men on long-term
androgen deprivation therapy for prostate cancer. J Natl Cancer Inst 102:1760–1770
Goel A, Arnold CN, Niedzwiecki D, Chang DK, Ricciardiello L, Carethers JM et al (2003)
Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res 63
(7):1608–1614
Goel A, Nagasaka T, Arnold CN et al (2007) The CpG island methylator phenotype and chromo-
somal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132
(1):127–138
Grady WM (2004) Genomic instability and colon cancer. Cancer Metastasis Rev 23(1–2):11–27
Grygiel-Górniak B (2014) Peroxisome proliferator-activated receptors and their ligands: nutritional
and clinical implications--a review. Nutr J 13:17. https://doi.org/10.1186/1475-2891-13-17
Guraya SY (2015) Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-
analysis and systematic review. World J Gastroenterol 21:6026–6031
Hamilton SR, Bosman FT, Boffetta P et al (2010) Carcinoma ofthe colon and rectum. In: Bosman
FT, Carneiro F, Hruban RH, Theise ND (eds) WHO classification of Tumoursof the digestive
system. IARC Press, Lyon, pp 134–146
Han FF, Guo CL, Liu LH (2013) The effect of CHEK2 variant I157T on cancer susceptibility:
evidence from a meta-analysis. DNA Cell Biol 32(6):329–335. https://doi.org/10.1089/dna.
2013.1970
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674.
https://doi.org/10.1016/j.cell.2011.02.013
156 M. Z. Banday et al.
https://t.me/medicina_free
Hernando E, Nahle Z, Juan G, Diaz-Rodriguez E, Alaminos M, Hemann M et al (2004) Rb
inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic
control. Nature 430(7001):797–802. https://doi.org/10.1038/nature02820
Hoeijmakers JH, Egly JM, Vermeulen W (1996) TFIIH: a keycomponent in multiple DNA
transactions. Curr Opin Genet Dev 6:26–33
Howlader N, Noone AM, Krapcho M et al (eds) (2019) SEER Cancer Statistics Review, 1975-2016.
National Cancer Institute, Bethesda, MD
Hung RJ, Hall J, Brennan P, Boffetta P (2005) Genetic polymorphisms in the base excision repair
pathway and cancer risk: aHuGE review. Am J Epidemiol 162:925–942
Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL et al (2019 Jan) Discovery of
common and rare genetic risk variants for colorectal cancer. Nat Genet 51(1):76–87. https://doi.
org/10.1038/s41588-018-0286-6
Iacopetta B, Grieu F, Amanuel B (2010) Microsatellite instability in colorectal cancer. Asia Pac J
Clin Oncol 6(4):260–269. https://doi.org/10.1111/j.1743-7563.2010.01335.x
Jakobsen A, Nielsen JN, Gyldenkerne N, Lindeberg J (2005) Thymidylate synthase and
methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of
fluorouracil sensitivity. J Clin Oncol 23(7):1365–1369. https://doi.org/10.1200/JCO.2005.06.
219
Janani C, Ranjitha Kumari BD (2015) PPAR gamma gene--a review. Diabetes & metabolic
syndrome 9(1):46–50. https://doi.org/10.1016/j.dsx.2014.09.015
Jelsig AM, Qvist N, Brusgaard K et al (2014) Hamartomatous polyposis syndromes: a review.
Orphanet J Rare Dis 9:101. https://doi.org/10.1186/1750-1172-9-101
Jian R, Beaune P, Laurent-Puig P (2004) Thymidylate synthase gene polymorphism predicts
toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy. Clin Cancer
Res 10(17):5880–5888. https://doi.org/10.1158/1078-0432.CCR-04-0169
Jiang Y, Ben Q, Shen H et al (2011) Diabetes mellitus and incidence and mortality of colorectal
cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol 26:863–876
Jiraskova K, Hughes DJ, Brezina S, Gumpenberger T, Veskrnova V, Buchler T et al (2018)
Functional polymorphisms in DNA repair genes are associated with sporadic colorectal Cancer
susceptibility and clinical outcome. Int J Mol Sci 20(1):97. https://doi .org/10.339 0/
ijms20010097
Karahalios A, Simpson JA, Baglietto L et al (2016) Change in weight and waist circumference and
risk of colorectal cancer: results from the Melbourne collaborative cohort study. BMC Cancer
16:157
Karki R, Pandya D, Elston RC, Ferlini C (2015) Defining “mutation” and “polymorphism” in the
era of personal genomics. BMC Med Genet 8:37. https://doi.org/10.1186/s12920-015-0115-z
Kennell J, Cadigan KM (2009) APC and beta-catenin degradation. Adv Exp Med Biol 656:1–12
Khoram-Abadi KM, Forat-Yazdi M, Kheirandish S, Saeidi N, Zarezade Z, Mehrabi N,
Neamatzadeh H (2016) DNMT3B -149 C>T and 579 G>T polymorphisms and risk of
gastric and colorectal Cancer: a Meta-analysis. Asian Pac J Cancer Prev 17(6):3015–3020
Kim MS, Lee J, Sidransky D (2010) DNA methylation markers in colorectal cancer. Cancer
Metastasis Rev 29(1):181–206. https://doi.org/10.1007/s10555-010-9207-6
Kim SE, Paik HY, Yoon H et al (2015) Sex- and gender-specific disparities in colorectal cancer risk.
World J Gastroenterol 21:5167–5175
Klungland A, Bjelland S (2007) Oxidative damage to purines in DNA: role of mammalian Ogg1.
DNA Repair 6:481
–488
Knudsen KE, Diehl JA, Haiman CA, Knudsen ES (2006) Cyclin D1: polymorphism, aberrant
splicing and cancer risk. Oncogene 25(11):1620–1628. https://doi.org/10.1038/sj.onc.1209371
Kohno T, Shinmura K, Tosaka M, Tani M et al (1998) Genetic polymorphisms and alternative
splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged
DNA. Oncogene 16:3219–3225
5 Colorectal Cancer and Genetic Polymorphism in Key Regulatory Low... 157
https://t.me/medicina_free
Kong S, Wei Q, Amos CI, Lynch PM, Levin B, Zong J, Frazier ML (2001) Cyclin D1 polymor-
phism and increased risk of colorectal cancer at young age. J Natl Cancer Inst 93
(14):1106–1108. https://doi.org/10.1093/jnci/93.14.1106
Kowalska-Loth B, Bubko I, Komorowska B, Szumiel I, Staron K (1998) Contribution of topoisom-
erase I to conversion of single-strand into double strand DNA breaks. Mol Biol Rep 25:21–26
Kuipers EJ, Grady WM, Lieberman D et al (2015) Colorectal cancer. Nat Rev Dis Primers 1:15065.
https://doi.org/10.1038/nrdp.2015.65
Lagergren J, Ye W, Ekbom A (2001) Intestinal cancer after cholecystectomy: is bile involved in
carcinogenesis? Gastroenterology 121:542–547
Lakatos PL, Lakatos L (2008) Risk for colorectal cancer in ulcerative colitis: changes, causes and
management strategies. World J Gastroenterol 14(25):3937–3947. https://doi.org/10.3748/wjg.
14.3937
Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB et al (2012) Contribution of screening and survival
differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomark Prev
21:728–736
Law PJ, Timofeeva M, Fernandez-Rozadilla C, Broderick P, Studd J, Fernandez-Tajes J,
Farrington S, Svinti V et al (2019) Association analyses identify 31 new risk loci for colorectal
cancer susceptibility. Nat Commun 10(1):2154. https://doi.org/10.1038/s41467-019-09775-w
Le Marchand L, Donlon T, Lum-Jones A, Seifried A, Wilkens LR (2002) Association of the
hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomark Prev
11:409–412
Leclerc D, Wilson A, Dumas R (1998) (1998) cloning and mapping of a cDNA for methionine
synthase reductase, a flavoprotein defective in patients with homo-cystinuria. Proc Natl Acad
Sci U S A 95(6):3059–3064
Lecomte O, Hivroz C, Mazerolles F, Fischer A (1994) Differential CD4-dependent regulation of
naive and memory CD4+ T cell adhesion is not related to differences in expression and function
of CD4 and p56lck. Int Immunol 6(4):551–559. https://doi.org/10.1093/intimm/6.4.551. PMID:
7912545
Lee J, Xiao YY, Sun YY, Balderacchi J, Clark B, Desani J, Kumar V, Saverimuthu A, Win KT,
Huang Y, Xu Y (2017) Prevalence and characteristics of hereditary non-polyposis colorectal
cancer (HNPCC) syndrome in immigrant Asian colorectal cancer patients. BMC Cancer 17
(1):843
Lenz HJ, Zhang W, Zhahedy S, Gil J, Yu M, Stoehlmacher J (2002) A 6 base-pair deletion in the
3
0
UTR of the thymidylate synthase (TS) gene predicts TS mRNA expression in colorectal
tumors. A possible candidate gene for colorectal cancer risk. Proc Am Assoc Cancer Res 43:660
Levine AJ, Figueiredo JC, Lee W, Conti DV, Kennedy K, Duggan DJ, Poynter JN, Campbell PT
et al (2010) A candidate gene study of folate-associated one carbon metabolism genes and
colorectal cancer risk. Cancer Epidemiol Biomark Prev 19(7):1812 – 1821. https://doi.org/10.
1158/1055-9965
Li X, Dumont P, Della PA, Shetler C, Murphy ME (2005) The codon 47 polymorphism in p53 is
functionally significant. J Biol Chem 280:24245–24251
Liang PS, Chen TY, Giovannucci E (2009) Cigarette smoking and colorectal cancer incidence and
mortality: systematic review and meta-analysis. Int J Cancer 124:2406–2415
Liang J, Lin C, Hu F, Wang F, Zhu L, Yao X, Wang Y, Zhao Y (2013) APC polymorphisms and the
risk of colorectal neoplasia: aHuGE review and meta-analysis. Am J Epidemiol 177:1169–1179.
https://doi.org/10.1093/aje/kws382
Liang X, Fan X, Tan K, Zhang L, Jian L, Yu L (2018) Peroxisome proliferators-activated receptor
gamma polymorphisms and colorectal cancer risk. J Cancer Res Ther 14:S306–S310. https://
doi.org/10.4103/0973-1482.235346
Liu C, Wang QS, Wang YJ (2012) The CHEK2 I157T variant and colorectal cancer susceptibility: a
systematic review and meta-analysis. Asian Pac J Cancer Prev 13(5):2051–2055. https://doi.org/
10.7314/apjcp.2012.13.5.2051
158 M. Z. Banday et al.
https://t.me/medicina_free
Liu L, Miao L, Ji G, Qiang F, Liu Z, Fan Z (2013) Association between XRCC1 and XRCC3
polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies. Mol Biol
Rep 40(6):3943–3952. https://doi.org/10.1007/s11033-012-2471-5
Liu Y et al (2014) Association between statin use and colorectal cancer risk: a meta-analysis of
42 studies. Cancer Causes Control 25:237–249
Lu YL, Li GL, Huang HL, Zhong J, Dai LC (2010) Peroxisome proliferator-activated receptor-
gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis. World J
Gastroenterol 16(17):2170–2175. https://doi.org/10.3748/wjg.v16.i17.2170
Lung JC, Chu JS, Yu JC, Yue CT, Lo YL, Shen CY et al (2002) Aberrant expression of cell-cycle
regulator cyclin D1 in breast cancer is related to chromosomal genomic instability. Genes
Chromosomes Cancer 34(3):276–284. https://doi.org/10.1002/gcc.10072
Makar GA, Holmes JH, Yang YX (2014) Angiotensin-converting enzyme inhibitor therapy and
colorectal cancer risk. J Natl Cancer Inst 106:djt374
Mandola MV, Stoehlmacher J, Muller-Weeks S et al (2003) A novel single nucleotide polymor-
phism within the 5
0
tandem repeat polymorphism of the thymidylate synthase gene abolishes
USF-1 binding and alters transcriptional activity. Cancer Res 63:2898–2904
Mármol I, Sánchez-de-Diego C, PradillaDieste A, Cerrada E, Rodriguez Yoldi MJ (2017) Colorec-
tal carcinoma: a general overview and future perspectives in colorectal Cancer. Int J Mol Sci 18
(1):197. https://doi.org/10.3390/ijms18010197
McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C (2012) Cancer chromosomal
instability: therapeutic and diagnostic challenges. EMBO Rep 13(6):528–538. https://doi.org/
10.1038/embor.2012.61
Moertel CG (1994) Chemotherapy for colorectal cancer. N Engl J Med 330:1136–1142
Murphy ME (2006) Polymorphic variants in the p53 pathway. Cell Death Differ 13(6):916–920
Namazi A, Abedinzadeh M, Nourbaksh P, Neamatzadeh H (2015) Association between the XRCC3
Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and
6,645 controls. Asian Pac J Cancer Prev 16(6):2263–2268. https://doi.org/10.7314/apjcp.2015.
16.6.2263
Nassiri M, Kooshyar MM, Roudbar Z, Mahdavi M, Doosti M (2013) Genes and SNPs associated
with non-hereditary and hereditary colorectal cancer. Asian Pac J Cancer Prev 14
(10):5609–5614. https://doi.org/10.7314/apjcp.2013.14.10.5609
Nazki FH, Sameer AS, Ganaie BA (2014) Folate: metabolism, genes, polymorphisms and the
associated diseases. Gene 533(1):11–20. https://doi.org/10.1016/j.gene.2013.09.063
Nissar S, Sameer AS, Rasool R, Rashid F (2014) DNA repair gene--XRCC1 in relation to genome
instability and role in colorectal carcinogenesis. Oncol Res Treat 37(7–8):418–422. https://doi.
org/10.1159/000364898
Nissar S, Sameer AS, Rasool R, Chowdri NA, Rashid F (2015) Polymorphism of the DNA repair
gene XRCC1 (Arg194Trp) and its role in colorectal Cancer in Kashmiri population: a case
control study. Asian Pac J Cancer Prev 16(15):6385–6390. https://doi.org/10.7314/apjcp.2015.
16.15.6385
Nottage K, McFarlane J, Krasin MJ et al (2012) Secondary colorectal carcinoma after childhood
cancer. J Clin Oncol 30:2552–2558
O'Brien MJ, Winawer SJ, Zauber AG, Bushey MT, Sternberg SS, Gottlieb LS et al (2004) Flat
adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially
or during surveillance? Clin Gastroenterol Hepatol 2(10):905–911
Ohayon T, Gershoni-Baruch R, Papa MZ, Distelman Menachem T, Eisenberg Barzilai S, Friedman
E (2005) The R72P P53 mutation is associated with familial breast cancer in Jewish women. Br
J Cancer 92(6):1144–1148. https://doi.org/10.1038/sj.bjc.6602451
Ortiz GJ, Li Y, Post SM, Pant V, Xiong S, Larsson CA, El-Naggar AK, Johnson DG, Lozano G
(2018) Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes. Onco-
gene 37(3):332–340. https://doi.org/10.1038/onc.2017.344
Ose J, Botma A, Balavarca Y, Buck K, Scherer D, Habermann N et al (2018) Pathway analysis of
genetic variants in folate-mediated one-carbon metabolism-related genes and survival in a
prospectively followed cohort of colorectal cancer patients. Cancer Med 7(7):2797–2807.
https://doi.org/10.1002/cam4.1407
5 Colorectal Cancer and Genetic Polymorphism in Key Regulatory Low... 159
https://t.me/medicina_free
Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE (2005) Noninvasive testing for colorectal cancer:
a review. Am J Gastroenterol 100(6):1393–1403. https://doi.org/10.1111/j.1572-0241.2005.
41427.x
Pabalan N, Singian E, Tabangay L, Jarjanazi H, Singh N (2015) Associations of the A66G
methionine synthase Reductase polymorphism in colorectal Cancer: a systematic review and
Meta-analysis. Biomark Cancer 7(Suppl 1):21–28. https://doi.org/10.4137/BIC.S25251
Pan Z, Chen M, Hu X, Wang H, Yang J, Zhang C, Pan F, Sun G (2018) Associations between VDR
gene polymorphisms and colorectal cancer susceptibility: an updated meta-analysis based on
39 case-control studies. Oncotarget 9(16):13068–13076. https://doi.org/10.18632/oncotarget.
23964
Pang Y, Kartsonaki C, Guo Y et al (2018) Diabetes, plasma glucose and incidence of colorectal
cancer in Chinese adults: a prospective study of 0.5 million people. J Epidemiol Commun
Health 72:919 – 925
Paz MF, Avila S, Fraga MF (2002) (2002) germ-line variants in methyl-group metabolism genes
and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res
62:4519–4524
Pietsch EC, Humbey O, Murphy ME (2006) Polymorphisms in the p53 pathway. Oncogene 25
(11):1602–1611. https://doi.org/10.1038/sj.onc.1209367
Pike JW, Meyer MB (2012) The vitamin D receptor: new paradigms for the regulation of gene
expression by 1,25-dihydroxyvitamin D3. Rheum Dis Clin N Am 38(1):13–27. https://doi.org/
10.1016/j.rdc.2012.03.004
Pino MS, Chung DC (2010) The chromosomal instability pathway in colon cancer. Gastroenterol-
ogy 138(6):2059– 2072. https://doi.org/10.1053/j.gastro.2009.12.065
Plentz RR, Wiemann SU, Flemming P, Meier PN, Kubicka S, Kreipe H et al (2003) Telomere
shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorec-
tal cancer. Gut 52(9):1304–1307
Power DG, Gloglowski E, Lipkin SM (2010) Clinical genetics of hereditary colorectal cancer.
Hematol Oncol Clin North Am 24(5):837–859. https://doi.org/10.1016/j.hoc.2010.06.006
Purim O, Gordon N, Brenner B (2013) Cancer of the colon and rectum: potential effects of sex-age
interactions on incidence and outcome. Med Sci Monitor 19:203–209. https://doi.org/10.12659/
msm.883842
Qin X, Peng Q, Tang W, Lao X, Chen Z, Lai H, Deng Y, Mo C et al (2013) An updated meta-
analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk. PLoS
One 8(9):e76031. https://doi.org/10.1371/journal.pone.0076031
Qiu H, Cheng C, Wang Y, Kang M, Tang W, Chen S, Gu H, Liu C, Chen Y (2016) Investigation of
cyclin D1 rs9344 G>a polymorphism in colorectal cancer: a meta-analysis involving 13,642
subjects. Onco Targets Ther 9:6641–6650. https://doi.org/10.2147/OTT.S116258
Rai V (2015) Evaluation of the MTHFR C677T polymorphism as a risk factor for colorectal cancer
in Asian populations. Asian Pac J Cancer Prev 16(18):8093–8100. https://doi.org/10.7314/
apjcp.2015.16.18.8093
Rawla P, Sunkara T, Muralidharan P, Pradeep Raj J (2018) Update in global trends and aetiology of
hepatocellular carcinoma. Contemp Oncol 22:141–150
Rawla P, Sunkara T, Barsouk A (2019) Epidemiology of colorectal cancer: incidence, mortality,
survival, and risk factors. Prz Gastroenterol 14(2):89–103. https://doi.org/10.5114/pg.2018.
81072
Richardson C (2005) RAD51, genomic stability, and tumorigenesis. Cancer Lett 218:127–139
Robsahm TE, Aagnes B, Hjartaker A et al (2013) Body mass index, physical activity, and colorectal
cancer by anatomical subsites: a systematic review and meta-analysis of cohort studies. Eur J
Cancer Prev 22:492–505
Rothwell PM, Wilson M, Elwin CE et al (2010) Long-term effect of aspirin on colorectal cancer
incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376:1741–
1750
Saadatzadeh MR, Elmi AN, Pandya PH, Bijangi-Vishehsaraei K, Ding J, Stamatkin CW, Cohen-
Gadol AA, Pollok KE (2017) The role of MDM2 in promoting genome stability versus
instability. Int J Mol Sci 18(10):2216. https://doi.org/10.3390/ijms18102216
160 M. Z. Banday et al.
https://t.me/medicina_free
Saffroy R, Lemoine A, Debuire B (2005) MTHFR (5,10-Methylenetetrahydrofolate reductase).
Atlas Genet Cytogenet Oncol Haematol. http://AtlasGeneticsOncology.org/Genes/
MTHFRID41448ch1p36.html. Accessed 20 Oct 2020
Sameer AS (2013a) A Colorectal cancer: molecular mutations and polymorphisms. Front
Oncologia 3:114. https://doi.org/10.3389/fonc.2013.00114
Sameer AS (2013b) Colorectal cancer: a researcher's perspective of the molecular angel's gone
eccentric in the Vale of Kashmir. Tumour Biol 34(3):1301–1315. https://doi.org/10.1007/
s13277-013-0692-4
Sameer AS, Nissar S (2018) XPD-the lynchpin of NER: molecule, gene, polymorphisms, and role
in colorectal carcinogenesis. Front Mol Biosci 5:23. https://doi.org/10.3389/fmolb.2018.00023
Sameer AS, Shah ZA, Abdullah S, Chowdri NA, Siddiqi MA (2011) Analysis of molecular
aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population. Hum
Genomics 5(5):441–452. https://doi.org/10.1186/1479-7364-5-5-441
Sameer AS, Nissar S, Abdullah S, Chowdri NA, Siddiqi MA (2012) DNA repair gene
8-oxoguanine DNA glycosylase Ser326Cys polymorphism and colorectal cancer risk in a
Kashmiri population. DNA Cell Biol 31(4):541–546. https://doi.org/10.1089/dna.2011.1349
Sameer AS, Nissar S, Fatima K (2014) Mismatch repair pathway: molecules, functions, and role in
colorectal carcinogenesis. Eur J Cancer Prev 23(4):246–257
Sánchez-Martínez R, Zambrano A, Castillo AI, Aranda A (2008) Vitamin D-dependent recruitment
of corepressors to vitamin D/retinoid X receptor heterodimers. Mol Cell Biol 28
(11):3817–3829. https://doi.org/10.1128/MCB.01909-07
Santarelli RLL, Pierre F, Corpet DE (2008) Processed meat and colorectal cancer: a review of
epidemiologic and experimental evidence. Nutr Cancer 60:131–144. https://doi.org/10.1080/
01635580701684872
Sarraf P, Mueller E, Smith WM, Wright HM, Kum JB, Aaltonen LA, de la Chapelle A, Spiegelman
BM, Eng C (1999) Loss-of-function mutations in PPAR gamma associated with human colon
cancer. Mol Cell 3(6):799–804. https://doi.org/10.1016/s1097-2765(01)80012-5
Savas S, Liu G (2009) Studying genetic variations in cancer prognosis (and risk): a primer for
clinicians. Oncologist 14:657–666
Serrano D, Gnagnarella P, Raimondi S, Gandini S (2016) Meta-analysis on vitamin D receptor and
cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms. Eur J Cancer Prev 25
(1):85–96. https://doi.org/10.1097/CEJ.0000000000000132
Sharp L, Little J (2004) Polymorphisms in genes involved in folate metabolism andcolorectal
neoplasia: aHuGE review. Am J Epidemiol 159:423–443
Shen MR, Jones IM, Mohrenweiser H (1998) Nonconservative amino acid substitution variants
exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res
58:604–608
Sheng X, Zhang Y, Zhao E, Lu S, Zheng X, Ge H, Lu W (2012) MTHFR C677T polymorphism
contributes to colorectal cancer susceptibility: evidence from 61 case-control studies. Mol Biol
Rep 39(10):9669–9679. https://doi.org/10.1007/s11033-012-1832-4
Sherr CJ, Roberts JM (2004) Living with or without cyclins and cyclin-dependent kinases. Genes
Dev 18(22):2699–2711. https://doi.org/10.1101/gad.1256504
Shinmura K, Yokota J (2001) The OGG1 gene encodes a repair enzyme for oxidatively damaged
DNA and is involved in human carcinogenesis. Antioxid Redox Signal 3:597–609
Song M, Garrett WS, Chan AT (2015) Nutrients, foods, and colorectal cancer prevention. Gastro-
enterology 148:1244–1260
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP (2006) Microsatellite instability in colorectal
cancer. Br J Surg 93(4):395–406. https://doi.org/10.1002/bjs.5328
Spruck CH, Won KA, Reed SI (1999) Deregulated cyclin E induces chromosome instability. Nature
401(6750):297–300. https://doi.org/10.1038/45836
Stoffel EM, Kastrinos F (2014) Familial colorectal cancer, beyond lynch syndrome. Clin
Gastroenterol Hepatol 12:1059–
1068
5 Colorectal Cancer and Genetic Polymorphism in Key Regulatory Low... 161
https://t.me/medicina_free
Stolz A, Ertych N, Bastians H (2011) Tumor suppressor CHK2: regulator of DNA damage response
and mediator of chromosomal stability. Clin Cancer Res 17(3):401–405. https://doi.org/10.
1158/1078-0432.CCR-10-1215
Sudmant PH, Rausch T, Gardner EJ, Handsaker RE, Abyzov A, Huddleston J et al (2015) An
integrated map of structural variation in 2,504 human genomes. Nature 526(7571):75–81.
https://doi.org/10.1038/nature15394
Sung P, Bailly V, Weber C, Thompson LH, Prakash L, Prakash S (1993) Human xeroderma
pigmentosum group D gene encodes a DNA helicase. Nature 365:852–855
Surveillance, Epidemiology, and End Results (SEER) Program (2016) (www.seer.cancer.gov)
SEER*Stat Database: Incidence – SEER 18 Regs Research Data + Hurricane Katrina Impacted
Louisiana Cases, Nov 2015 Sub (1973–2013 varying) – Linked To County Attributes – Total U.
S., 1969–2014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program,
Surveillance Systems Branch
Tan SC (2018) Low penetrance genetic polymorphisms as potential biomarkers for colorectal
cancer predisposition. J Gene Med 20(4):e3010. https://doi.org/10.1002/jgm.3010
Tebbs RS, Zhao Y, Tucker JD, Scheerer JB, Siciliano MJ, Hwang M, Liu N, Legerski RJ,
Thompson LH (1995) Correction of chromosomal instability and sensitivity to diverse
mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc Natl Acad Sci
92(14):6354–6358
Thacker J, Zdzienicka MZ (2004) The XRCC genes: expanding roles in DNA double-strand break
repair. DNA Repair 3:10811090
Thiagalingam S, Laken S, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B et al (2001)
Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad
Sci U S A 98(5):2698–2702. https://doi.org/10.1073/pnas.051625398
Thomas M, Kalita A, Labrecque S, Pim D et al (1999) Two polymorphic variants of wild-type p53
differ biochemically and biologically. Mol Cell Biol 19:1092–1100
Thompson LH, Schild D (2001) Homologous recombinational repair of DNAensures mammalian
chromosome stability. Mutat Res 477:131–153
Thosani N, Thosani SN, Kumar S et al (2013) Reduced risk of colorectal cancer with use of oral
bisphosphonates: a systematic review and meta-analysis. J Clin Oncol 31:623–630
Tian X, Dai S, Sun J, Jiang S, Jiang Y (2017) The association between theTP53 Arg72Pro
polymorphism and colorectal cancer: an updatedmeta-analysis based on 32 studies. Oncotarget
8:1156–1165
Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global Cancer incidence and mortality rates and
trends--an update. Cancer Epidemiol Biomarkers Prev 25(1):16–27. https://doi.org/10.1158/
1055-9965.epi-15-0578
Torre LA, Islami F, Siegel RL, Ward EM, Jemal A (2017 Apr) Global cancer in women: burden and
trends. Cancer Epidemiol Biomark Prev 26(4):444–457. https://doi.org/10.1158/1055-9965.
EPI-16-0858
Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hunter DJ (2005) APC Asp1822Val and Gly2502Ser
polymorphisms and risk of colorectal cancer and adenoma. Cancer Epidemiol Biomark Prev 14
(4):863–870. https://doi.org/10.1158/1055-9965.EPI-04-0687
Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM et al (2002) C-Myc can induce
DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for
oncogene-induced genetic instability. Mol Cell 9(5):1031–1044
Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y,
White R, Smits AM, Bos JL (1988) Genetic alterations during colorectal-tumor development.
N Engl J Med 319(9):525–532. https://doi.org/10.1056/NEJM198809013190901
Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D (2009) Genetic prognostic
and predictive markers in colorectal cancer. Nat Rev Cancer 9:489–499
Wang D, DuBois RN (2013) The role of anti-inflammatory drugs in colorectal cancer. Annu Rev
Med 64:131 –
144. https://doi.org/10.1146/annurev-med-112211-154330
162 M. Z. Banday et al.
https://t.me/medicina_free
Wang Z, Zhang W (2013) Association between XRCC3 Thr241Met polymorphism and colorectal
cancer risk. Tumour Biol 34(3):1421–1429. https://doi.org/10.1007/s13277-012-0639-1
Wang T, Xu J, Yu X, Yang R, Han ZC (2006 Apr) Peroxisome proliferator-activated receptor
gamma in malignant diseases. Crit Rev Oncol Hematol 58(1):1 – 14. https://doi.org/10.1016/j.
critrevonc.2005.08.011
Wang B, Wang D, Huang G, Zhang C, Xu DH, Zhou W (2010) XRCC1 polymorphisms and risk of
colorectal cancer: a meta-analysis. Int J Color Dis 25(3):313–321. https://doi.org/10.1007/
s00384-009-0866-0
Wang JJ, Zheng Y, Sun L et al (2011) TP53 codon 72 polymorphism andcolorectal cancer
susceptibility: a meta-analysis. Mol Biol Rep 38:4847–4853
Wang Y, Gao X, Wei F, Zhang X, Yu J, Zhao H, Sun Q, Yan F, Yan C, Li H, Ren X (2015) The
hOGG1 Ser326Cys polymorphism contributes to digestive system cancer susceptibility: evi-
dence from 48 case-control studies. Tumour Biol 36(2):1029–1038. https://doi.org/10.1007/
s13277-014-2710-6
Wang L, Qian J, Ying C, Zhuang Y, Shang X, Xu F (2016) X-ray cross-complementing groups
1 rs1799782 C>T polymorphisms and colorectal cancer susceptibility: a meta-analysis based on
Chinese Han population. J Cancer Res Ther 12(Suppl):C264–C267
Wang J, Ouyang N, Qu L, Lin T, Zhang X, Yu Y et al (2017a) Effect of MTHFR A1298C and
MTRR A66G genetic mutations on homocysteine levels in the Chinese population: a systematic
review and meta-analysis. J Transl Int Med 5(4):220–229. https://doi.org/10.1515/jtim-2017-
0037
Wang N, Lu Y, Khankari NK, Long J, Li HL, Gao J et al (2017b) Evaluation of genetic variants in
association with colorectal cancer risk and survival in Asians. Int J Cancer 141(6):1130–1139.
https://doi.org/10.1002/ijc.30812
Wei B, Zhou Y, Xu Z, Xi B, Cheng H, Ruan J et al (2011) The effect of hOGG1 Ser326Cys
polymorphism on cancer risk: evidence from a meta-analysis. PLoS One 6(11):e27545. https://
doi.org/10.1371/journal.pone.0027545
Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA et al (2006) CpG
island methylator phenotype underlies sporadic microsatellite instability and is tightly
associated with BRAF mutation in colorectal cancer. Nat Genet 38(7):787–793. https://doi.
org/10.1038/ng1834
Wen J, Xu Q, Yuan Y (2018) Single nucleotide polymorphisms and sporadic colorectal cancer
susceptibility: a field synopsis and meta-analysis. Cancer Cell Int 18:155. https://doi.org/10.
1186/s12935-018-0656-2
Whibley C, Pharoah PD, Hollstein M (2009) p53 polymorphisms: cancer implications. Nat Rev
Cancer 9(2):95–107. https://doi.org/10.1038/nrc2584
Wick W, Petersen I, Schmutzler RK, Wolfarth B, Lenartz D, Bierhoff E, Hümmerich J, Müller DJ,
Stangl AP, Schramm J, Wiestler OD (1996) Evidence for a novel tumor suppressor gene on
chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene
12(5):973–978
Wong HL, Peters U, Hayes RB, Huang WY, Schatzkin A, Bresalier RS, Velie EM, Brody LC
(2010) Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal
adenoma risk. Eur J Cancer 46(13):2457–2466. https://doi.org/10.1016/j.ejca.2010.04.020
World Cancer Research Fund/American Institute for Cancer Research (2011) Continuous update
project report. Food, nutrition, physical activity, and the prevention of colorectal cancer. http://
www.dietandcance rreport.org/cancer_resource_center/downloads/cu/Colorectal-Cancer -2011-
Report.pdf
Xiang HP, Geng XP, Ge WW, Li H (2011) Meta-analysis of CHEK2 1100delC variant and
colorectal cancer susceptibility. Eur J Cancer 47(17):2546–2551. https://doi.org/10.1016/j.
ejca.2011.03.025
Xie M, Zhao F, Zou X, Jin S, Xiong S (2017) The association between CCND1 G870A polymor-
phism and colorectal cancer risk: a meta-analysis. Medicine 96(42):e8269. https://doi.org/10.
1097/MD.0000000000008269
Xin J, Du M, Gu D, Ge Y, Li S, Chu H et al (2019) Combinations of single nucleotide
polymorphisms identified in genome-wide association studies determine risk for colorectal
cancer. Int J Cancer 145(10):2661–2669. https://doi.org/10.1002/ijc.32267
5 Colorectal Cancer and Genetic Polymorphism in Key Regulatory Low... 163
https://t.me/medicina_free
Xu W, Li Y, Wang X, Chen B, Liu S, Wang Y et al (2010) PPAR gamma polymorphisms and
cancer risk: a meta-analysis involving 32,138 subjects. Oncol Rep 24(2):579–585
Xu XM, Ni XB, Yang GL, Luo ZG, Niu YM, Shen M (2016) CCND1 G870A polymorphism and
colorectal cancer risk: an updated meta-analysis. Mol Clin Oncol 4(6):1078–1084. https://doi.
org/10.3892/mco.2016.844
Yamada A, Komaki Y, Komaki F et al (2018) Risk of gastrointestinal cancers in patients with cystic
fibrosis: a systematic review and meta-analysis. Lancet Oncol 19:758–767
Yang Y, Wang F, Shi C, Zou Y, Qin H, Ma Y (2012) Cyclin D1 G870A polymorphism contributes
to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studies.
PLoS One 7(5):e36813. https://doi.org/10.1371/journal.pone.0036813
Yoshimura K, Hanaoka T, Ohnami S, Ohnami S et al (2003) Allele frequencies of single nucleotide
polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: data
from population-based Japanese random samples. J Hum Genet 48:654–658
Young JP, Win AK, Rosty C, Flight I, Roder D, Young GP et al (2015) Rising incidence of early-
onset colorectal cancer in Australia over two decades: report and review. J Gastroenterol
Hepatol 30(1):6–13. https://doi.org/10.1111/jgh.12792
Yu K, Yang J, Jiang Y, Song R, Lu Q (2014) Vitamin D receptor BsmI polymorphism and
colorectal cancer risk: an updated analysis. Asian Pac J Cancer Prev 15(12):4801–4807.
https://doi.org/10.7314/apjcp.2014.15.12.4801
Zauber AG, O'Brien MJ, Winawer SJ (2002) On finding flat adenomas: is the search worth the gain?
Gastroenterology 122(3):839–840
Zhan T, Rindtorff N, Boutros M (2017) Wnt signaling in cancer. Oncogene 36(11):1461–1473.
https://doi.org/10.1038/onc.2016.304
Zhang M, Mo R (2014) Association of hOGG1 Ser326Cys polymorphism with colorectal cancer
risk: an updated meta-analysis including 5235 cases and 8438 controls. Tumour Biol
35:12627–12633
Zhang BB, Wang DG, Xuan C, Sun GL, Deng KF (2014a) Genetic 135G/C polymorphism of
RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls. Familial
Cancer 13(4):515–526. https://doi.org/10.1007/s10689-014-9729-0
Zhang T, Zhang DM, Zhao D, Hou XM, Ma SC, Liu XJ (2014b) Lack of association between the
XPD Lys751Gln polymorphism and colorectal cancer risk: a meta-analysis. Onco. Targets Ther
7:1255–1260. https://doi.org/10.2147/OTT.S66291
Zhang LZ, Li YS, Liu HZ (2015a) Meta-analysis of the relationship between XRCC3 T241M
polymorphism and colorectal cancer susceptibility. Genet Mol Res 14(4):14831–14839. https://
doi.org/10.4238/2015
Zhang X, Pageon L, Post SM (2015b) Impact of the Mdm2(SNP309-G) allele on a murine model of
colorectal cancer. Oncogene 34(33):4412–4420. https://doi.org/10.1038/onc.2014.377
Zhang Y, Liu H, Li L et al (2017) Cholecystectomy can increase the risk of colorectal cancer: a
meta-analysis of 10 cohort studies. PLoS One 12:e0181852
Zhang Y, Wu S, Zhou X, Huang F, Chen R, Wang Y, Wu J (2019) Association between nucleotide
excision repair gene polymorphism and colorectal cancer risk. J Clin Lab Anal 33(8):e22956.
https://doi.org/10.1002/jcla.22956
Zhao Z, Feng Q, Yin Z et al (2017) Red and processed meat consumption and colorectal cancer risk:
a systematic review and meta-analysis. Oncotarget 8:83306–83314
Zhou D, Mei Q, Luo H, Tang B, Yu P (2012a) The polymorphisms in methylenetetrahydrofolate
reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal
cancer. Int J Biol Sci 8(6):819–830. https://doi.org/10.7150/ijbs.4462
Zhou JY, Shi R, Yu HL, Zeng Y, Zheng WL, Ma WL (2012b) The association between two
polymorphisms in the TS gene and risk of cancer: a systematic review and pooled analysis. Int J
Cancer 131(9):2103–2116. https://doi.org/10.1002/ijc.27465
Zisman AL, Nickolov A, Brand RE, Gorchow A, Roy HK (2006) Associations between the age at
diagnosis and location of colorectal cancer and the use of alcohol and tobacco: implications for
screening. Arch Intern Med 166(6):629–634. https://doi.org/10.1001/archinte.166.6.629
164 M. Z. Banday et al.
https://t.me/medicina_free
Соседние файлы в папке Библиотека им академика М.И. Перельмана